Spis treści:
Spis załącznikĂłw:
3JR_Q1_2017_FS.zip (REPORT)
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Spis załącznikĂłw:
3JR_Q1_2017_FS.zip (REPORT)
| POLISH FINANCIAL SUPERVISION AUTHORITY | |||||||||||
| UNI - EN REPORT No | 27 | / | 2017 | ||||||||
| Date of issue: | 2017-05-30 | ||||||||||
| Short name of the issuer | |||||||||||
| SOPHARMA AD | |||||||||||
| Subject | |||||||||||
| CONSOLIDATED FINANCIAL STATEMENTS FOR THE PERIOD ENDING 31 MARCH 2017 | |||||||||||
| Official market - legal basis | |||||||||||
| art. 56. 1. 2 of Act on Public Offering. | |||||||||||
| Unofficial market - legal basis | |||||||||||
| Contents of the report: | |||||||||||
| 1. Financial Statements 2. Notes to the Financial Statements 3. Management report 4. Templates of the financial reports approved by the Bulgarian FSC 5. Declaration 6. Annex 9 7. Additional information 8. List of insider information of reg. 596(EU)/2014 |
|||||||||||
| Annexes | |||||||||||
| File | Description | ||||||||||
| 3JR_Q1_2017_FS.zip3JR_Q1_2017_FS.zip | CONSOLIDATED FINANCIAL STATEMENTS FOR THE PERIOD ENDING 31 MARCH 2017 | ||||||||||
| SOPHARMA AD | |||||||||||||
| (fullname of the issuer) | |||||||||||||
| SOPHARMA AD | Farmaceutyczny (far) | ||||||||||||
| (short name of the issuer) | (sector according to clasification of the WSE in Warsow) |
||||||||||||
| 1220 | Sofia | ||||||||||||
| (post code) | (city) | ||||||||||||
| IlienskoShosse | 16 | ||||||||||||
| (street) | (number) | ||||||||||||
| +359 2 813 42 00 | +359 2 936 02 86 | ||||||||||||
| (phone number) | (fax) | ||||||||||||
| (e-mail) | (web site) | ||||||||||||
| nd | |||||||||||||
| (NIP) | (REGON) | ||||||||||||
| SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |||||
| Date | Name | Position / Function | Signature | ||
| 2017-05-30 | Ognian Donev | Executive director | |||